Clearside Biomedical Ownership | Who Owns Clearside Biomedical?


OverviewForecastRevenueFinancialsChartTranscripts

Clearside Biomedical Ownership Summary


Clearside Biomedical is owned by 11.46% institutional investors, 13.02% insiders, and 75.53% retail investors. Vanguard group is the largest institutional shareholder, holding 3.75% of CLSD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.55% of its assets in Clearside Biomedical shares.

CLSD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockClearside Biomedical11.46%13.02%75.53%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group2.81M3.75%$2.67M
Carmignac gestion1.51M1.94%$1.21M
Blackrock798.14K1.14%$1.04M
Geode capital management764.06K1.02%$726.02K
Renaissance721.79K0.97%$685.70K
Blackrock funding, inc. /de625.19K0.80%$500.15K
First manhattan co. llc.342.73K0.44%$274.18K
State street265.26K0.35%$252.00K
Bridgeway capital management255.00K0.34%$242.25K
Morgan stanley145.99K0.21%$189.79K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Brown wealth management100.00K0.02%$80.00K
Carmignac gestion1.51M0.02%$1.21M
Newman dignan & sheerar30.12K0.01%$24.10K
Bridgeway capital management255.00K0.01%$242.25K
Northeast financial consultants93.00K0.00%$88.35K
Gen-wealth partners10.00K0.00%$8.00K
Renaissance721.79K0.00%$685.70K
First manhattan co. llc.342.73K0.00%$274.18K
Rockwood wealth management10.00K0.00%$8.00K
Stratos wealth advisors14.00K0.00%$11.20K

Top Buyers

HolderShares% AssetsChange
Ubs group145.12K-145.12K
State street265.26K-60.10K
Blackrock798.14K-39.91K
Susquehanna group, llp59.04K-38.72K
Geode capital management764.06K0.00%32.67K

Top Sellers

HolderShares% AssetsChange
Armistice capital---2.14M
Gcm grosvenor---198.69K
Blackrock funding, inc. /de625.19K--175.73K
Castleview partners---161.96K
Rosalind advisors---127.22K

New Positions

HolderShares% AssetsChangeValue
Ubs group145.12K-145.12K$137.86K
Oppenheimer14.34K0.00%14.34K$13.62K
Gen-wealth partners10.00K0.00%10.00K$8.00K
Raymond james financial999.00-999.00$799.00
Royal bank of canada568.00-568.00$1.00K

Sold Out

HolderChange
Qube research-4.00
Russell investments group-145.00
Householder group estate & retirement specialist-385.00
Larson financial group-1.00K
Jones financial companies lllp-1.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202547-8,812,320-6.64%117.18%10-50.00%1566.67%
Dec 31, 202441-22.64%8,729,652-13.15%116.46%17-15.00%7-41.67%
Sep 30, 2024533.92%10,051,240-27.00%133.46%2017.65%12-29.41%
Jun 30, 202451-7.27%13,768,135-11.32%193.12%17-45.16%17183.33%
Mar 31, 20245512.24%15,525,337100.43%2516.09%3193.75%6-45.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.97M2.55%-
Vanguard Total Stock Mkt Idx Inv1.93M2.46%-42.15K
Carmignac Pf L-S Eurp Eqs F EUR Acc1.51M1.94%-
Vanguard Institutional Extnd Mkt Idx Tr880.90K1.12%-401.40K
Fidelity Extended Market Index378.61K0.49%-988.00
Bridgeway Ultra-Small Company Market255.00K0.33%-
Carmignac Absolute Ret Eur A EUR Acc175.19K0.23%-146.13K
iShares Micro-Cap ETF146.01K0.19%-
Fidelity Total Market Index139.56K0.18%-
BlackRock Extended Equity Market K126.61K0.17%-54.00

Recent Insider Transactions


DateNameRoleActivityValue
Feb 24, 2025Thorp Clay-Buy$13.80K
Nov 01, 2024Chong Ngai Hang Victor Chief Medical OfficerBuy$36.50K
Jun 24, 2024Chong Ngai Hang Victor Chief Medical OfficerBuy$24.91K
May 15, 2024YERXA BENJAMIN R-Buy$10.24K
Apr 17, 2024Gibney Anthony S-Buy$8.39K

Insider Transactions Trends


DateBuySell
2025 Q11-
2024 Q41-
2024 Q24-
2024 Q132
2023 Q44-

CLSD Ownership FAQ


Who Owns Clearside Biomedical?

Clearside Biomedical shareholders are primarily institutional investors at 11.46%, followed by 13.02% insiders and 75.52% retail investors. The average institutional ownership in Clearside Biomedical's industry, Biotech Stocks , is 64.05%, which Clearside Biomedical falls below.

Who owns the most shares of Clearside Biomedical?

Clearside Biomedical’s largest shareholders are Vanguard group (2.81M shares, 3.75%), Carmignac gestion (1.51M shares, 1.94%), and Blackrock (798.14K shares, 1.14%). Together, they hold 6.84% of Clearside Biomedical’s total shares outstanding.

Does Blackrock own Clearside Biomedical?

Yes, BlackRock owns 1.14% of Clearside Biomedical, totaling 798.14K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.04M$. In the last quarter, BlackRock increased its holdings by 39.91K shares, a 5.26% change.

Who is Clearside Biomedical’s biggest shareholder by percentage of total assets invested?

Brown wealth management is Clearside Biomedical’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 100K Clearside Biomedical shares, valued at 80K$.

Who is the top mutual fund holder of Clearside Biomedical shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Clearside Biomedical shares, with 2.55% of its total shares outstanding invested in 1.97M Clearside Biomedical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools